These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Does adjuvant vaccine therapy really have activity in malignant melanoma? Wheatley K; Ives NJ; Lorigan P J Clin Oncol; 2007 Oct; 25(29):4693; author reply 4693-5. PubMed ID: 17925569 [No Abstract] [Full Text] [Related]
4. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma. Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052 [TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary treatment of primary melanoma. Yao K; Balch G; Winchester DJ Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240 [TBL] [Abstract][Full Text] [Related]
6. The adjuvant treatment of malignant melanoma. Reintgen D; Kirkwood J J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for melanoma. Sondak VK Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282 [TBL] [Abstract][Full Text] [Related]
8. Update on adjuvant interferon therapy for high-risk melanoma. Agarwala SS; Kirkwood JM Oncology (Williston Park); 2002 Sep; 16(9):1177-87; discussion 1190-2, 1197. PubMed ID: 12380946 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma. Mitchell MS; Abrams J; Thompson JA; Kashani-Sabet M; DeConti RC; Hwu WJ; Atkins MB; Whitman E; Ernstoff MS; Haluska FG; Jakowatz JG; Das Gupta TK; Richards JM; Samlowski WE; Costanzi JJ; Aronson FR; Deisseroth AB; Dudek AZ; Jones VE J Clin Oncol; 2007 May; 25(15):2078-85. PubMed ID: 17513813 [TBL] [Abstract][Full Text] [Related]
11. Update on the role of adjuvant interferon for high risk melanoma. Agarwala SS; Kirkwood JM Forum (Genova); 2000; 10(3):230-9. PubMed ID: 11007931 [TBL] [Abstract][Full Text] [Related]
12. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma]. Hauschild A; Lischner S; Christophers E Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for high-risk primary and resected metastatic melanoma. Hersey P Intern Med J; 2003; 33(1-2):33-43. PubMed ID: 12534876 [TBL] [Abstract][Full Text] [Related]
14. Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up. Rusciani L; Proietti I; Paradisi A; Rusciani A; Guerriero G; Mammone A; De Gaetano A; Lippa S Melanoma Res; 2007 Jun; 17(3):177-83. PubMed ID: 17505263 [TBL] [Abstract][Full Text] [Related]
15. Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice. Ravaud A; Bedane C; Geoffrois L; Lesimple T; Delaunay M Br J Cancer; 1999 Aug; 80(11):1767-9. PubMed ID: 10468294 [TBL] [Abstract][Full Text] [Related]